UMIN ID: UMIN000027557
Registered date:01/08/2017
Weight reduction by mazindol in morbid obesity with or without type 2 diabetes mellitus
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | obesity disease |
| Date of first enrollment | 2017/08/01 |
| Target sample size | 10 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | administration of mazindol: 0.5mg/day for 2 weeks, followed by 1mg/day for 2 weeks and 1.5mg/day for 2 months |
Outcome(s)
| Primary Outcome | Weight reduction rate in 3 months' administration of mazindol, with or without the use of SGLT2 inhibitor |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | 20years-old |
|---|---|
| Age maximum | 65years-old |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | Patients with contraindication for administration of mazindol or SGLT2 inhibitor |
Related Information
| Primary Sponsor | Fukuoka University Hospital |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Fukuoka University Hospital |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Makito Tanabe |
| Address | 7-45-1, Nanakuma, Jonan-ku, Fukuoka, Japan Japan 8140180 |
| Telephone | 092-801-1011 |
| mtanabe@live.jp | |
| Affiliation | Fukuoka University Hospital Department of Endocrinology and Diabetes Mellitus |
| scientific contact | |
| Name | Makito Tanabe |
| Address | 7-45-1, Nanakuma, Jonan-ku, Fukuoka, Japan Japan |
| Telephone | 092-801-1011 |
| mtanabe@live.jp | |
| Affiliation | Fukuoka University Hospital Department of Endocrinology and Diabetes Mellitus |